Clinical Scorecard: Digging in to Inherited Retinal Disease

At a Glance

Key Highlights

• Advances in multimodal imaging (widefield color photography, FAF, OCT, NIR, OCTA) enable detailed retinal evaluation and differentiation of IRDs from AMD.
• Genetic testing confirms IRD diagnosis, clarifies inheritance patterns, informs prognosis, and identifies eligibility for clinical trials and emerging therapies.
• Functional testing (FFERG, dark adaptation, visual fields, color vision, contrast sensitivity) complements imaging to assess retinal function and disease progression.

Guideline-Based Recommendations

Diagnosis

• Use widefield color photography and fundus autofluorescence (FAF) to assess retinal pigment epithelium health and identify characteristic IRD patterns.
• Employ optical coherence tomography (OCT) and near-infrared imaging (NIR) for detailed retinal layer analysis and detection of sub-retinal abnormalities.
• Consider OCT angiography (OCTA) to detect early choroidal neovascularization in IRDs with increased CNV risk.
• Order genetic testing to confirm IRD genotype and inheritance, especially when clinical features are atypical or family history is absent.
• Use full-field electroretinography (FFERG) to objectively evaluate global retinal function and differentiate IRD from localized diseases like AMD.
• Apply dark adaptation testing in early IRD diagnosis to detect delayed rod function, particularly in retinitis pigmentosa.

Management

• Initiate anti-vascular endothelial growth factor (anti-VEGF) treatment promptly upon detection of choroidal neovascularization to improve visual outcomes.
• Provide patient education on disease variability and prognosis based on genotype and phenotype correlations.
• Refer patients for genetic counseling and consider enrollment in clinical trials or emerging gene therapies when appropriate.

Monitoring & Follow-up

• Perform serial visual field testing to monitor disease progression and functional impact.
• Repeat multimodal imaging to track structural retinal changes over time.
• Assess functional vision parameters including color vision and contrast sensitivity to capture comprehensive visual status.

Risks

• Misdiagnosis of IRD as age-related macular degeneration (AMD) can delay appropriate management.
• Choroidal neovascularization is a common complication in many IRDs, requiring vigilant surveillance and early intervention.
• Genetic heterogeneity and variable expressivity may complicate prognosis and family counseling.

Patient & Prescribing Data

Adults presenting with advanced retinal degeneration or atypical macular disease features, including those without known family history of vision loss

Genetic testing can reveal pathogenic variants such as PRPH2 mutations causing pattern dystrophies; treatment includes monitoring for CNV and use of anti-VEGF therapy when indicated; nutritional supplements used for AMD may not be appropriate for IRD masqueraders

Clinical Best Practices

• Maintain high suspicion for IRD in patients with unusual retinal findings or atypical progression for age-related macular degeneration.
• Utilize a combination of multimodal imaging and functional testing to differentiate IRD from other retinal diseases.
• Incorporate genetic testing early in the diagnostic process to guide prognosis and therapeutic options.
• Educate patients about the variable nature of IRDs and the implications of genetic findings.
• Coordinate care with genetic counselors and retinal specialists for comprehensive management.

References

• PRPH2 Gene and Associated Retinal Conditions